The T7-ASO-lipid nanoparticles decreased the expression of Bcl2 and Akt-1in LC cell lines, exhibited superior antitumor effects, and improved the overall survival (OS) in LC xenograft bearing mice [224]. The gene discussed is AKT1; the disease is laryngotracheoesophageal cleft.